A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder,Journal of Child and Adolescent Psychopharmacology

当前位置： X-MOL 学术 › J. Child Adolesc. Psychopharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder
Journal of Child and Adolescent Psychopharmacology ( IF 1.5 ) Pub Date : 2021-11-16 , DOI: 10.1089/cap.2021.0077
Scott H Kollins _{1,

2} , Rene Braeckman ₃ , Sven Guenther ₃ , Andrew C Barrett ₃ , Travis C Mickle ₃ , Charles Oh ₄ , Andrea Marraffino ₅ , Andrew J Cutler _{6,

7} , Matthew N Brams ₈

Affiliation

Objectives: To evaluate the efficacy and safety of once-daily serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) capsules (Azstarys^™) compared with placebo in children with attention-deficit/hyperactivity disorder (ADHD) in a randomized, double-blind, dose-optimized laboratory classroom study.

中文翻译：

对注意力缺陷/多动障碍儿童服用哌醋甲酯和 d-哌醋甲酯胶囊的随机、对照实验室课堂研究

目的：为了评估每日一次serdexmethylphenidate /右哌甲酯的疗效和安全性（SDX / d-MPH）胶囊（Azstarys^™）与同在一个随机，双盲注意力缺陷/多动障碍（ADHD）儿童安慰剂相比，剂量优化的实验室课堂研究。

更新日期：2021-11-17

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11